Researchers propose a new model for classifying Parkinson’s disease

The antibody, which has been called Ab-IPL-IL-17, targets a sequence in both IL-17A and IL-17F. It has demonstrated positive results for rheumatoid arthritis treatment in

The FDA iden­ti­fied is­sues with main­te­nance and clean­ing at a Catal­ent man­u­fac­tur­ing fa­cil­i­ty re­spon­si­ble for the FDA re­jec­tion of a new ver­sion of Re­gen­eron’s block­buster